Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina.
- 1 June 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 81 (6) , 1887-1898
- https://doi.org/10.1161/01.cir.81.6.1887
Abstract
To investigate the mechanism of antianginal action of the calcium channel blocker nisoldipine and to determine the reproducibility of the clinical and hemodynamic events induced by supine leg exercise, 30 patients with stable effort angina pectoris were studied. They were divided into two groups; one group of 19 patients received a single 10-mg dose of nisoldipine orally, and the other group of 11 patients received a single dose of placebo orally. Chest pain was induced in all of 30 patients during the control exercise test. After nisoldipine administration, chest pain was not induced in 13 of 19 patients and was of lessened severity in five patients with the same work load as those performing control exercise. ST segment at peak exercise showed less severe depression after nisoldipine. Systemic vascular resistance was reduced by 38% (p less than 0.001) at rest and 22% (p less than 0.001) at peak exercise, and coronary vascular resistance was reduced by 31% (p less than 0.01) at rest and 18% (p less than 0.01) at peak exercise. Pulmonary artery wedge pressure fell from 6 +/- 1 to 3 +/- 1 mm Hg (p less than 0.001) at rest and from 28 +/- 3 to 11 +/- 2 mm Hg (p less than 0.001) at peak exercise. Coronary sinus flow at rest and myocardial oxygen uptake both at rest and during exercise was not modified by nisoldipine. However, coronary sinus flow at peak exercise increased significantly from 219 +/- 24 to 249 +/- 31 ml/min (p less than 0.01) after nisoldipine, and myocardial oxygen uptake was not significantly changed despite decreased coronary vascular resistance. The clinical and hemodynamic events induced by the exercise during invasive studies (except pulmonary artery wedge pressure at rest) were reproducible after placebo administration. Our data demonstrate that increased coronary blood flow could be the major mechanism of the antianginal action of nisoldipine in supine leg exercise-induced angina.This publication has 32 references indexed in Scilit:
- Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Influence of exercise on coronary sinus blood flow determinationsThe American Journal of Cardiology, 1987
- Evaluation of antianginal effects of nisoldipine (BAY k 5552) by serial multistage treadmill exercise testing.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1987
- Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patientsAmerican Heart Journal, 1985
- The effect of a calcium channel antagonist, Nisoldipine, on the ischemia-induced change of canine sarcolemmal membraneBasic Research in Cardiology, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Real-Time Radionuclide Cineangiography in the Noninvasive Evaluation of Global and Regional Left Ventricular Function at Rest and during Exercise in Patients with Coronary-Artery DiseaseNew England Journal of Medicine, 1977
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971
- Left Ventricular Hemodynamics in Exercise-Induced Angina PectorisCirculation, 1968
- A new system of multiple-lead exercise electrocardiographyAmerican Heart Journal, 1966